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Introduction: Wilson disease is rarely reported among African children. This report describes the second case
report of a Nigerian child with Wilson disease in three decades.
Case presentation: An eight-year-old African boy presented with generalized oedema and ascites and proteinuria.
Over the next three weeks he developed conjugated hyperbilirubinaemia, severe coagulopathy and prominent
extrapyramidal features consisting of rigidity, tremors at rest and in action, shuffling gait, slurred speech and
emotional lability. Slit-lamp examination of his eyes revealed Kayser-Fleischer rings and sunflower cataracts. His
serum caeruloplasmin level was 5mg/dL. Using the scoring system proposed by the 8th International Meeting of
Wilson Disease and Menkes Disease, a diagnosis of Wilson disease was made.
Conclusions: Wilson disease does occur in African children, although the diagnosis is rarely made. A diagnosis of
Wilson disease should be entertained in the evaluation of African children presenting with liver dysfunction and/or
extrapyramidal neurological features.Introduction
Wilson Disease (WD) is a rare autosomal recessive disease
resulting in a systemic overload of copper. The reported
prevalence is 30 per million people [1]. However, apart
from a report three decades ago, WD has not been
described in children in Nigeria [2]. In this report we de-
scribe another Nigerian child with WD and highlight that,
though uncommonly diagnosed in African children, WD
should also be considered in the differential diagnosis of a
clinical presentation of liver disease and/or extrapyramidal
manifestation in children in Africa.Case presentation
An eight-year-old African boy, previously well, was re-
ferred to our unit on account of nephrotic syndrome. He
had presented to our emergency department a day be-
fore with ascites, facial swelling and reduced urinary out-
put in the preceding two weeks. After two days of
hospitalization, he became deeply jaundiced with wor-
sening of the generalized oedema. A day later, he had
three brief episodes of generalized clonic seizures over a
two-hour period and became increasingly drowsy. The
seizures were aborted with diazepam and he remained* Correspondence: esezobor@gmail.com
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reproduction in any medium, provided the orseizure-free after a short course of phenobarbitone. A
physical examination did not support a diagnosis of
meningitis and other aspects of a neurological examin-
ation were normal. He had ascites and non-tender hep-
atomegaly; his spleen was not palpable. A review of his
history did not reveal chronic or recent use of orthodox
or non-orthodox medicines. In addition, there was no
previous or current history of similar illness in his four
siblings and close contacts. Both his parents were Afri-
cans, of the Igbo ethnic group from southeast Nigeria,
but were not known to be blood relatives.
In the second week of hospitalization, our patient devel-
oped tremors of his hands while at rest and when reaching
for objects. He became clumsy when performing chores
involving the use of his hands. Subsequently, he was
observed to be stiff globally, with his trunk arched forward
and fisting of the hands (left more than right). His gait
was noticed to be shuffling with a tendency to fall forward
when trying to walk. At the same time, his face retained a
wry smile and his speech became slurred and dysarthric.
He frequently complained of generalized body pain and
derived some relief when his clenched fist was helped
open. He was also noticed to be emotionally labile; he
cried inconsolably when asking for food. He was reviewed
by a paediatric neurologist who pointed out the possible
presence of Kayser-Fleischer (KF) rings on both eyes. A
slit-lamp examination by an ophthalmologist promptlyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Serum bilirubin: Total, Direct (mg/dL) 18.8, 14.0 0.5, 0.3
Serum protein (mg/dL) 5.3 6.3
Serum albumin (mg/dL) 3.4 1.1
Serum alanine transaminase (IU/L) 6 176
Serum aspartate transaminase (IU/L) 8 254
Serum alkaline phosphatase (IU/L) 24 258
Serum gamma-glutamyltransferase (IU/L) 40 49
Plasma thromboplastin: Test, Control (sec) 30.5, 82.0 30.5, 39.0
Prothrombin time: Test, Control (sec) 14.1, 85.3 14.1, 39.0
International normalized ratio 11.7 4.0
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flower cataracts.
Initial investigations showed proteinuria of grade 1+
and a spot urine protein to creatinine ratio of 1. Table 1
shows the results for his liver function test during
hospitalization. His serum electrolytes, urea and creatin-
ine were within the normal reference range. An abdom-
inal ultrasound scan revealed ascites and hepatomegaly
with increased liver parenchymal echoes but no dilated
intra- or extrahepatic ducts. However, his gall bladder
was enlarged with a thickened wall and sludge within.
Serology for human immunodeficiency virus, hepatitis B
and hepatitis C viruses were negative. A serum sample
for caeruloplasmin level was returned as having 5mg/dL
of caeruloplasmin, using an immunoturbidimetric
method (reference range: 25 to 45mg/dL).
Using the scoring system proposed by the 8th Inter-
national Meeting of Wilson Disease and Menkes Disease
[3], our patient achieved a score of 6 (compatible neuro-
psychiatric features = 2; K-F rings = 2 and caeruloplasmin
level of 5mg/dL =2) and a diagnosis of WD was made.
His diet was restricted to high calorie, low protein and
low copper meals. Vitamins, including vitamin K, and
lactulose and neomycin were commenced. Control of
the generalized oedema was achieved with furosemide
and spironolactone. Long-term zinc and pyridoxine ther-
apy was started. The use of trihexyphenidyl helped
achieved some control of the spasticity and rigidity, suf-
ficient to allow resumption of basic activities such as
walking and holding objects. His liver dysfunction also
improved, with near resolution of the international nor-
malized ratio (from 12 to 4).
Discussion
WD is a rare autosomal recessive disorder resulting in
copper overload. Most cases have been reported inFigure 1 A slit-lamp examination showing Kayser-Fleischer ring
(black arrow).developed countries [4-6]. Apart from North Africa,
where several cases of WD have been described, the diag-
nosis is rarely made in children and adults in Africa [7-9].
The higher frequency of detection in North Africa com-
pared with the rest of Africa may be explained by the
higher rate of consanguinity in North Africa, which makes
an autosomal recessive disease more likely to occur [7].
Children with WD are usually normal at birth and may
remain healthy for a variable period of time; most cases
present in the second and third decade of life [4]. Our pa-
tient had conjugated hyperbilirubinaemia, ascites and se-
vere dysfunction of the synthetic activity of his liver.
Although he had proteinuria and generalized oedema,
which informed the initial diagnosis of nephrotic syn-
drome, the proteinuria never reached nephrotic range and
the progression of the oedema (ascites preceding pedal
oedema) did not support a renal aetiopathogenesis for the
generalized oedema. Indeed, it is now known that persons
with WD could have some degree of proximal tubulopa-
thy, which may be partial (as may be the case in our pa-
tient) or generalized (Fanconi syndrome) [10,11].
The neurological features of WD are primarily due to
the deposition of copper in the lenticular nuclei, al-
though areas like the brainstem and cerebellum can be
affected [12]. In our patient, neurologic features devel-
oped within three weeks of hepatic presentation, and in
the absence of the use of copper chelating drugs. He had
most of the neurologic features described in the litera-
ture: rigidity, dystonia, dysarthria, tremor at rest, festi-
nant gait and insomnia [1,12]. He was also emotionally
labile with abrupt mood changes. Predominance of
mood features in some patients explains the not uncom-
mon presentation to psychiatrists [4]. In the presence of
significant hepatic derangement, we viewed the seizures
he had in the early phase of his hospitalization as part of
the clinical features of hepatic encephalopathy.
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to make a definite diagnosis in our patient. A score of 4 or
more makes the diagnosis of WD likely. This scoring sys-
tem has been validated with high sensitivity and specificity
as well as high positive and negative predictive values [6].
The long-term treatment of symptomatic cases of WD
entails the chronic use of copper chelators and zinc,
while liver transplantation provides a cure [1,5]. The
copper chelators commonly used for WD are penicilla-
mine and trientine hydrochloride but these chelators are
not available in Nigeria. While we attempt to source
trientine abroad, we based our decision to commence a
zinc-based treatment on a case series which showed
favourable improvement in symptomatic children treated
with zinc only [13].
Conclusion
We have described the second known case of WD in a
Nigerian child, its rarity in the African population, and
highlighted the varied clinical manifestations of the
disease.
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